Hybrid Androgen Receptor Inhibitors Outperform Enzalutamide and EPI-001 in in vitro Models of Prostate Cancer Drug Resistance. (2023)

First Author: Nicolescu RCB
Attributed to:  Diversity-Oriented Synthesis of Stapled Peptides funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/cmdc.202200548

PubMed Identifier: 36300876

Publication URI: http://europepmc.org/abstract/MED/36300876

Type: Journal Article/Review

Volume: 18

Parent Publication: ChemMedChem

Issue: 2

ISSN: 1860-7179